Kriya Therapeutics Completes $100 Million Series B Financing To Advance Its Fully Integrated Platform For Designing, Developing And Manufacturing Transformative Gene Therapies
Kriya Therapeutics Completes $100 Million Series B Financing To Advance Its Fully Integrated Platform For Designing, Developing And Manufacturing Transformative Gene Therapies
07/14/21, 12:10 PM
Money raised
$100 million
Round Type
series b
Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, today announced the closing of a $100 Million Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies.